Plasma oxalate and glycolate levels in patients with chronic kidney disease (CKD stage 4 and 5).

Completed

• Conditions: Hyperoxaluria; Oxalosis; 10027424; 10038430

• Registration Number: NL-OMON52424
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

Patients with estimated glomerular filtration rate < 30 ml/min/1,73 m2
regardless the underlying cause of renal insufficiency.

Exclusion Criteria

Patients who are unable to give informed consent.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Reference values for plasma oxalate levels in patients with ESRD. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Reference values for plasma glycolate levels in patients with ESRD. </p><br>